Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro

References

• Bai N, He K, Zhou Z, et al. (2010). Flavonoids from Rabdosia rubescens exert anti-inflammatory and growth inhibitory effect against human leukemia HL-60 cells. Food Chem 122:831–5
   Web of Science ®Google Scholar
• Chen L, Liang Y, Ruan J, et al. (2004). Reversal of P-gp mediated multidrug resistance in vitro and in vivo by FG020318. J Pharm Pharmacol 56:1061–6
   PubMedGoogle Scholar
• China Pharmacopoeia Committee. (2010). Pharmacopoeia of the People s Republic of China. Beijing: China Medical Science Press, 106
   Google Scholar
• Fojo T, Bates S. (2003). Strategies for reversing drug resistance. Oncogene 22:7512–23
   PubMed Web of Science ®Google Scholar
• Fu L, Liang Y, Deng L, et al. (2004). Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Chemoth Pharm 53:349–56
   PubMed Web of Science ®Google Scholar
• Gao A, Wang X, Xiang W, et al. (2010). Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin. J Pharm Pharmacol 62:393–9
   PubMedGoogle Scholar
• Gottesman MM. (2002). Mechanisms of cancer drug resistance. Annu Rev Med 53:615–27
   PubMed Web of Science ®Google Scholar
• Guo J, Pan X, Feng C, Zou J. (2002). Study on reversal effects of oridonin on multidrug resistant cell line K562/A02. Shanghai Med J 25:43–5
   Google Scholar
• Hsieh T, Wijeratne EK, Liang J, et al. (2005). Differential control of growth, cell cycle progression, and expression of NF-κB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb Rabdosia rubescens. Biochem Biophys Res Commun 337:224–31
   PubMed Web of Science ®Google Scholar
• Huang M, Jin J, Sun H, Liu GT. (2008). Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae. Cancer Chemoth Pharm 62:1015–26
   PubMed Web of Science ®Google Scholar
• Ji BS, He L, Liu GQ. (2005). Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Life Sci 77:2221–32
   PubMed Web of Science ®Google Scholar
• Kang N, Zhang JH, Qiu F, et al. (2010). Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways. Cancer Lett 294:147–58
   PubMed Web of Science ®Google Scholar
• Krishna R, Mayer LD. (2000). Multidrug resistance (MDR) in cancer: Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 11:265–83
   PubMed Web of Science ®Google Scholar
• Lage H. (2003). ABC-transporters: Implications on drug resistance from microorganisms to human cancers. Int J Antimicrob Ag 22:188–99
   PubMed Web of Science ®Google Scholar
• Lee JJ, Swain SM. (2005b). Development of novel chemotherapeutic agents to evade the mechanisms of multidrug resistance (MDR). Semin Oncol 32:22–6
   PubMed Web of Science ®Google Scholar
• Li C, Wang E, Cheng Y, Bao J. (2011). Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics. Int J Biochem Cell B 43:701–4
   PubMed Web of Science ®Google Scholar
• Ling V. (1997). Multidrug resistance: Molecular mechanisms and clinical relevance. Cancer Chemoth Pharm 40:3–8
   PubMed Web of Science ®Google Scholar
• Lu Y, Sun C, Liu R, Pan Y. (2007). Effective two-dimensional counter-current chromatographic method for simultaneous isolation and purification of oridonin and ponicidin from the crude extract of Rabdosia rubescens. J Chromatogr A 1146:125–30
   PubMed Web of Science ®Google Scholar
• Perloff MD, Störmer E, von Moltke LL, Greenblatt DJ. (2003). Rapid assessment of P-glycoprotein inhibition and induction in vitro. Pharm Res 20:1177–83
   PubMed Web of Science ®Google Scholar
• Schwarz RE, Donohue CA, Sadava D, Kane SE. (2003). Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: Implications for monotherapy and combination treatment. Cancer Lett 189:59–68
   PubMed Web of Science ®Google Scholar
• Seiden MV, Swenerton KD, Matulonis U, et al. (2002). A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy. Gynecol Oncol 86:302–10
   PubMed Web of Science ®Google Scholar
• Shi L, Ma R, Lu R, et al. (2008). Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU. Cancer Lett 269:101–10
   PubMed Web of Science ®Google Scholar
• Szakacs G, Varadi A, Özvegy-Laczka C, Sarkadi B. (2008). The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME–Tox). Drug Discov Today 13:379–93
   PubMed Web of Science ®Google Scholar
• Theis JGW, Chan HSL, Greenberg ML, et al. (2000). Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma. Med Pediatr Oncol 34:242–9
   PubMedGoogle Scholar
• Tiwari AK, Sodani K, Wang SR, et al. (2009). Nilotinib (AMN107, Tasigna®) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters. Biochem Pharmacol 78:153–61
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y. (1981). Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967–72
   PubMed Web of Science ®Google Scholar
• Watt PM. (2006). Screening for peptide drugs from the natural repertoire of biodiverse protein folds. Nat Biotechnol 24:177–83
   PubMed Web of Science ®Google Scholar
• Xiao Y, Wang W. (2011). Empirical study of reverse effect on mediated multidrug resistance of U-2OS/ADM cells with curcumin in vitro. J Hyg Res 40:103--6
   Web of Science ®Google Scholar
• Xu Y, Xue Y, Wang Y, et al. (2009). Multiple-modulation effects of oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia. Int Immunopharmacol 9:360–5
   PubMed Web of Science ®Google Scholar
• Xu J, Yang JY, Ran Q, et al. (2008). Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates. Bioorg Med Chem Lett 18:4741–4
   PubMedGoogle Scholar